Skip to content 
What Have We Achieved So Far?
We began our journey in 2021 with the sale of 20,000 units. By 2022, that figure soared to 120,000 units, marking a remarkable 300% increase. In 2024, our total implant production reached 500,000 units. Looking ahead to 2025, our goal is to achieve sales in the range of 400,000 to 550,000 units, further solidifying our position in both domestic and global markets. This growth trajectory is a direct result of sound strategies, high-quality products, and our commitment to customer satisfaction.
Our Journey
Following four successful years of growth rates surpassing 100%, we anticipate that 2025 will be a pivotal year in strengthening our presence on the global stage. The significant milestones we’ve achieved so far instill confidence in our future aspirations, and the 300% sales increase trend is poised to continue with sustainable growth. By expanding our investments and implementing innovation-driven strategies, we will reinforce our leading position in the industry.
Global Distributor Network
Thanks to our global dealer network, you can access our business partners and dealers who provide uninterrupted service for the sale of our products.
Our approach
Innovations Shaping the Future
Science and Technology Focus
We aim to facilitate the surgical procedure with the implant systems we have developed in the light of advanced technology and scientific data.
Global Standards
By combining local expertise with global quality standards, we produce products that are used safely in 7 different countries.
Sustainability and Biocompatibility
We offer implants that are both environmentally friendly and safe with high-quality titanium and innovative surface technologies.
We prioritize innovative solutions, reliability and patient satisfaction
VenusCon
Highlights from our YouTube Channel!
